Education
About Us
Working with TipRanks
Follow Us
ONO Pharmaceutical Co (JP:4528)
:4528
Total Valuation
ONO Pharmaceutical Co has a market cap or net worth of ¥733.12B. The enterprise value is ¥1.39T.
Market Cap¥733.12B
Enterprise Value¥1.39T
Share Statistics
ONO Pharmaceutical Co has 498,692,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding498,692,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ONO Pharmaceutical Co’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.65%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.65%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee126.36M
Profits Per Employee12.99M
Employee Count3,853
Asset Turnover0.46
Inventory Turnover1.98
Valuation Ratios
The current PE Ratio of ONO Pharmaceutical Co is 15.04. ONO Pharmaceutical Co’s PEG ratio is 0.60.
PE Ratio15.04
PS Ratio0.00
PB Ratio1.49
Price to Fair Value0.96
Price to FCF13.19
Price to Operating Cash Flow10.71
PEG Ratio0.60
Income Statement
In the last 12 months, ONO Pharmaceutical Co had revenue of 486.87B and earned 50.05B in profits. Earnings per share was 106.55.
Revenue486.87B
Gross Profit338.92B
Operating Income63.38B
Pretax Income59.20B
Net Income50.05B
EBITDA91.42B
Earnings Per Share (EPS)106.55
Cash Flow
In the last 12 months, operating cash flow was 82.46B and capital expenditures -5.43B, giving a free cash flow of 77.03B billion.
Operating Cash Flow82.46B
Free Cash Flow77.03B
Free Cash Flow per Share154.46
Dividends & Yields
ONO Pharmaceutical Co pays an annual dividend of ¥40, resulting in a dividend yield of 5.12%
Dividend Per Share¥40
Dividend Yield5.12%
Payout Ratio37.54%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.41
52-Week Price Change-23.85%
50-Day Moving Average1.59K
200-Day Moving Average1.70K
Relative Strength Index (RSI)50.74
Average Volume (3m)2.57M
Important Dates
ONO Pharmaceutical Co upcoming earnings date is Aug 4, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 4, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
ONO Pharmaceutical Co as a current ratio of 3.07, with Debt / Equity ratio of 1.12%
Current Ratio3.07
Quick Ratio2.56
Debt to Market Cap0.18
Net Debt to EBITDA-0.63
Interest Coverage Ratio11.92
Taxes
In the past 12 months, ONO Pharmaceutical Co has paid 9.16B in taxes.
Income Tax9.16B
Effective Tax Rate0.15
Enterprise Valuation
ONO Pharmaceutical Co EV to EBITDA ratio is 7.60, with an EV/FCF ratio of 9.02.
EV to Sales1.43
EV to EBITDA7.60
EV to Free Cash Flow9.02
EV to Operating Cash Flow8.43
Balance Sheet
ONO Pharmaceutical Co has ¥209.05B in cash and marketable securities with ¥146.68B in debt, giving a net cash position of -¥62.37B billion.
Cash & Marketable Securities¥209.05B
Total Debt¥146.68B
Net Cash-¥62.37B
Net Cash Per Share-¥125.06
Tangible Book Value Per Share¥930.34
Margins
Gross margin is 74.71%, with operating margin of 13.02%, and net profit margin of 10.28%.
Gross Margin74.71%
Operating Margin13.02%
Pretax Margin12.16%
Net Profit Margin10.28%
EBITDA Margin18.78%
EBIT Margin13.25%
Analyst Forecast
The average price target for ONO Pharmaceutical Co is ¥1,400.58, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target¥1,400.58
Price Target Upside-10.28% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast-3.14%
EPS Growth Forecast-59.94%